Hawthorne Effect: Raises $20M in Series A Funding

Hawthorne Effect Raises $20M in Series A Funding

  • Hawthorne Effect, a San Francisco CA-based company which offers solutions for decentralizing clinical trials, raised $20M in Series A funding
  • The round was led by Northpond Ventures, with participation from SignalFire and P5 Health Ventures
  • The company intends to use the funds to accelerate growth and help scale operations
  • The company’s tech-driven platform, the Hawthorne Cloud, works with highly trained medical professionals
  • Since launching in 2015, the solution has been used across more than 50 clinical trials
  • The company is actively engaged with more than 260 clinical sites and also runs trials as a single virtual site
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

NatWest Group Strengthens Free Investment Guidance Programme

New initiative aims to educate more customers on investing.Highlights: NatWest Group expands free investment guidance programme.Initiative targets educating...

Tether Launches New Stablecoin Wallet to Enhance User Experience

This innovative platform aims to improve accessibility for crypto users.Highlights: Tether has introduced a new stablecoin wallet.The wallet...

FCA Strengthens Money Laundering Combat with Synthetic Dataset

New collaboration aims to enhance detection capabilities against financial crime.Highlights: FCA partners with Turing Institute to combat money...

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...